Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3
Jie Tang(State Key Laboratory of Biotherapy), Yongsheng Wang(Sichuan University)
Cited by 27
Related Papers
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
|Molecular Medicine Reports|2015|53
Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
|Frontiers in Oncology|2021|31